[Funding alert] OrbiMed Raises $4.3 Billion Across Private Investment Funds
Oct 25, 2023 | By Startup Rise EU
![OrbiMed Raises $4.3 Billion across private investment funds including OrbiMed Private Investments IX, OrbiMed Asia Partners V and OrbiMed Royalty & Credit Opportunities IV.](https://startuprise.co.uk/wp-content/uploads/2023/10/OrbiMed-Raises-4.3-Billion-Across-Private-Investment-Funds.webp)
OrbiMed Raises $4.3 Billion across private investment funds including OrbiMed Private Investments IX, OrbiMed Asia Partners V and OrbiMed Royalty & Credit Opportunities IV.
Consistent with their predecessors, these new funds enable OrbiMed to invest globally, from seed stage for start-ups incubated by OrbiMed through growth capital opportunities.
OrbiMed works closely with its portfolio companies to provide tailored financing solutions, which can include equity, credit and royalty-based financing.
Read also - Stockholm-based Hailey HR Raises €1.7 million in Funding
RECOMMENDED FOR YOU
OrbiMed focuses on innovative and growth-oriented opportunities across healthcare sub-sectors, including biopharmaceuticals, medical devices, diagnostics and technologyenabled healthcare services.
OrbiMed is led by its 21 partners, with a growing team exceeding 130 professionals that contribute diverse, complementary skills across company incubation, strategy, operations and finance.
Read also - Munich-based Lanes & Planes Secures $35 Million in Series B Round Funding
The firm’s professionals are based in a dozen global locations across key healthcare markets in North America, Europe and Asia. Investors in these new funds include a broad range of medical institutions, university endowments, foundations, pension funds, sovereign wealth funds and family offices.
Carter Neild, a Managing Partner of OrbiMed said, “OrbiMed is deeply appreciative of the continued support we’ve received from many long-standing partners who’ve invested in these funds, We will endeavor to meet our partners’ high expectations in the coming years.”
About OrbiMed
OrbiMed is a leading healthcare investment firm with more than $17 billion in assets under
management. OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds and royalty/credit funds.
Read also - UK-based Kao Data has Funding from Legal & General Capital and Infratil
OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies.
Recommended Stories for You
![story](https://startuprise.co.uk/wp-content/uploads/2024/01/Welcome-to-the-Jungle-Acquired-London-based-Job-Search-Platform-Otta-.webp)
Welcome to the Jungle Acquired London-based Job Search Platform Otta
Startup Rise EU Jan 23, 2024
![story](https://startuprise.co.uk/wp-content/uploads/2024/07/Amsterdam-based-Uncover-Legal-Secures-Funding-.webp)
Uncover Legal funding news – Amsterdam-based Uncover Legal Secures Funding
Startup Rise EU Jul 26, 2024
![story](https://startuprise.co.uk/wp-content/uploads/2023/11/Stockholm-based-Aonic-Acquires-NDREAMS-For-110-Million-.webp)
Stockholm-based Aonic Acquires NDREAMS For $110 Million
Startup Rise EU Nov 20, 2023
![story](https://startuprise.co.uk/wp-content/uploads/2023/11/Munich-Solar-Tech-Company-Sono-Motors-Secures-Investment-from-Yorkville.webp)
[Funding alert] Munich-based Solar Tech Company Sono Motors Secures Investment from Yorkville
Startup Rise EU Nov 28, 2023
![story](https://startuprise.co.uk/wp-content/uploads/2024/03/Danish-based-climatetech-company-NitroVolt-Secures-E750K-in-Pre-Seed-Funding-3.webp)
[Funding alert] Danish-based Climatetech Company NitroVolt Secures €750K in Pre-Seed Funding
Startup Rise EU Mar 8, 2024
![story](https://startuprise.co.uk/wp-content/uploads/2024/05/Prague-based-Product-Fruits-Raises-E1.47-Million-in-Funding-.webp)
Product Fruits funding news – Prague-based Product Fruits Raises €1.5 Million in Funding
Startup Rise EU May 29, 2024